The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams

OBJECTIVES: MRI is an integral part of breast cancer screening in high-risk patients. We investigated whether the application of the Kaiser score, a clinical decision-support tool, may be used to exclude malignancy in contrast-enhancing lesions classified as BI-RADS 4 on breast MRI screening exams....

Descripción completa

Detalles Bibliográficos
Autores principales: Milos, Ruxandra Iulia, Pipan, Francesca, Kalovidouri, Anastasia, Clauser, Paola, Kapetas, Panagiotis, Bernathova, Maria, Helbich, Thomas H., Baltzer, Pascal A. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Breast
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553895/
https://www.ncbi.nlm.nih.gov/pubmed/32504098
http://dx.doi.org/10.1007/s00330-020-06945-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553895/
https://www.ncbi.nlm.nih.gov/pubmed/32504098
http://dx.doi.org/10.1007/s00330-020-06945-z

Ejemplares similares